HF
TBPH icon

HRT Financial’s Theravance Biopharma TBPH Stock Holding History

HRT Financial’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.33M Buy
328,676
+95,824
+41% +$1.7M 0.01% 952
2025
Q4 		$4.36M Buy
232,852
+209,397
+893% +$3.47M 0.01% 842
2025
Q3 		$342K Sell
23,455
-35,375
-60% -$447K ﹤0.01% 2099
2025
Q2 		$648K Buy
58,830
+41,340
+236% +$402K ﹤0.01% 1490
2025
Q1 		$156K Buy
+17,490
New +$163K ﹤0.01% 2076
2024
Q3 		– Sell
-153,424
Closed -$1.3M – 3117
2024
Q2 		$1.3M Buy
153,424
+22,035
+17% +$199K 0.01% 897
2024
Q1 		$1.18M Buy
131,389
+53,170
+68% +$493K 0.01% 809
2023
Q4 		$879K Sell
78,219
-61,679
-44% -$621K 0.01% 1056
2023
Q3 		$1.21M Sell
139,898
-161,182
-54% -$1.56M 0.01% 872
2023
Q2 		$3.12M Buy
+301,080
New +$3.32M 0.03% 442
2022
Q4 		– Sell
-49,596
Closed -$502K – 3129
2022
Q3 		$502K Buy
49,596
+33,840
+215% +$317K 0.01% 1523
2022
Q2 		$142K Sell
15,756
-19,533
-55% -$180K ﹤0.01% 2350
2022
Q1 		$337K Sell
35,289
-2,264
-6% -$22.2K ﹤0.01% 2152
2021
Q4 		$414K Buy
+37,553
New +$327K ﹤0.01% 2040
2021
Q3 		– Sell
-16,150
Closed -$234K – 3744
2021
Q2 		$234K Buy
16,150
+6,320
+64% +$119K ﹤0.01% 2303
2021
Q1 		$200K Buy
+9,830
New +$187K ﹤0.01% 2312
2020
Q4 		– Sell
-21,083
Closed -$311K – 2447
2020
Q3 		$311K Buy
21,083
+4,155
+25% +$77.8K 0.01% 1120
2020
Q2 		$355K Buy
+16,928
New +$435K 0.01% 915

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's TBPH Position: Q1 2026 in Review

HRT Financial increased its Theravance Biopharma (TBPH) stake by 41% in Q1 2026, buying an estimated $1.7M and bringing the position to 328,676 shares worth $5.33M. The position accounts for 0.01% of the portfolio, ranked #952.

HRT Financial first reported a position in TBPH in Q2 2020 and has held it in 18 quarters since. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • HRT Financial held 328,676 shares of Theravance Biopharma worth $5.33M as of Q1 2026.
  • HRT Financial bought 95,824 Theravance Biopharma shares in Q1 2026, an estimated $1.7M.
  • Theravance Biopharma made up 0.01% of HRT Financial's portfolio in Q1 2026, its #952 holding.
  • HRT Financial first reported a position in Theravance Biopharma in Q2 2020 and has held it in 18 quarters since.
  • 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.